1. Home
  2. ISSC vs FHTX Comparison

ISSC vs FHTX Comparison

Compare ISSC & FHTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Innovative Solutions and Support Inc.

ISSC

Innovative Solutions and Support Inc.

HOLD

Current Price

$27.64

Market Cap

380.6M

Sector

Technology

ML Signal

HOLD

Logo Foghorn Therapeutics Inc.

FHTX

Foghorn Therapeutics Inc.

HOLD

Current Price

$4.81

Market Cap

332.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISSC
FHTX
Founded
1988
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
380.6M
332.2M
IPO Year
2000
2020

Fundamental Metrics

Financial Performance
Metric
ISSC
FHTX
Price
$27.64
$4.81
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$16.50
$11.50
AVG Volume (30 Days)
624.8K
126.7K
Earning Date
05-26-2026
06-11-2026
Dividend Yield
N/A
N/A
EPS Growth
120.00
25.32
EPS
0.22
N/A
Revenue
N/A
$30,909,000.00
Revenue This Year
$6.63
$14.62
Revenue Next Year
$8.13
$15.27
P/E Ratio
$126.95
N/A
Revenue Growth
N/A
36.75
52 Week Low
$5.30
$2.94
52 Week High
$30.98
$6.95

Technical Indicators

Market Signals
Indicator
ISSC
FHTX
Relative Strength Index (RSI) 57.75 35.07
Support Level $17.57 $4.44
Resistance Level N/A $5.85
Average True Range (ATR) 2.11 0.37
MACD -0.02 -0.09
Stochastic Oscillator 58.53 15.75

Price Performance

Historical Comparison
ISSC
FHTX

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

About FHTX Foghorn Therapeutics Inc.

Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.

Share on Social Networks: